| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.42B | -9.4% |
| Cost of Revenue | $1.90B | -9.3% |
| R&D Expense | $2.9M | -9.4% |
| SG&A Expense | $325.9M | -8.7% |
| Operating Income | $97.0M | +405.2% |
| Interest Expense | $50.5M | -21.7% |
| Pre-tax Income | $32.5M | +173.0% |
| Income Tax | $5.5M | -14.1% |
| Net Income | $27.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.3M | +116.8% |
| Accounts Receivable | $294.8M | +7.9% |
| Inventory | $143.5M | -11.6% |
| Current Assets | $538.4M | +0.8% |
| Total Assets | $1.25B | -3.5% |
| Current Liabilities | $624.2M | -10.7% |
| Long-term Debt | $369.9M | -1.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $95.9M | -15.1% |
| Capital Expenditures | $45.2M | -21.0% |
| Investing Cash Flow | -$27.7M | -318.1% |
| Financing Cash Flow | -$36.1M | +75.8% |
| Free Cash Flow | $50.7M | -9.0% |
| +153.0% |
| EPS (Basic) | $0.57 | +153.3% |
| EPS (Diluted) | $0.54 | +150.5% |
| Total Liabilities |
| $1.12B |
| -10.0% |
| Stockholders' Equity | -$59.5M | -219.2% |